As a hematologist with extensive experience in the field of blood disorders, I can provide you with an informed perspective on the current state of treatment for Immune Thrombocytopenia (ITP) in adults.

ITP is an autoimmune disorder where the body's immune system mistakenly attacks and destroys platelets, which are essential for blood clotting. While there is no definitive "cure" for ITP, there are several effective treatments that can manage the condition and significantly improve the quality of life for patients.

The primary goal of ITP treatment is to bring the platelet count to a safe level and to alleviate symptoms. Treatment options include:


1. Corticosteroids: These are often the first line of treatment and can quickly increase platelet count.

2. Intravenous Immunoglobulins (IVIG): These are given for short-term increase in platelet count, often used before a surgery or to manage acute bleeding.

3. Rituximab: A medication that works by targeting specific immune cells.

4. Splenectomy: The surgical removal of the spleen, which is where much of the platelet destruction occurs.

5. Newer medications: There are several newer therapies in development, including thrombopoietin receptor agonists like eltrombopag and romiplostim.

It's important to note that the choice of treatment depends on the severity of the condition, the patient's overall health, and the patient's response to initial treatments. Some patients may achieve long-term remission, while others may require ongoing treatment to manage their ITP.

read more >>

Even people with very low counts, can sometimes have few symptoms. Some adults with mild ITP may not need any treatment, but will be monitored with occasional blood tests. There is no cure for ITP and treatment is used to raise the platelet count to counteract symptoms.read more >>